ALAN J MAIN
CIK 1227372 · EVP, Innov & Chem Sciences · last filed 2025-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$540.3K
Companies
2
Total Filings
37
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | EVP, Innov & Chem Sciences | 281,391 | $1.92 | $540.3K | $0 | 36 | 2025-03-03 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Pharmaceutical Research | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings · Page 4 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-12-27 | LXRX | Exer (M) | +19,211 | $21.7K | EDGAR |
| 2011-02-25 | LXRX | Mixed | +13,411 | -$10.7K | EDGAR |
| 2010-02-17 | LXRX | Mixed | −7,314 | -$14.0K | EDGAR |
| 2009-08-14 | LXRX | Tax (F) | −5,924 | -$7.7K | EDGAR |
| 2009-02-17 | LXRX | Grant (A) | +44,800 | $0 | EDGAR |
| 2008-02-11 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2007-02-15 | LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–37 of 37
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.